Breaking News

You are here » Indian-Commodity  :  Corporate  :  Sun Pharma reports 7% rise in Q4 consolidated net profit

26-May2018

Sun Pharma reports 7% rise in Q4 consolidated net profit

Sun Pharmaceutical Industries has reported results for the fourth quarter and year ended March 31, 2018.

The company has reported a rise of 83.30% in its net profit at Rs 176.26 crore for the quarter ended March 31, 2018 as compared to Rs 96.16 crore for the same quarter in the previous year. Total income of the company increased by 21.08% at Rs 2460.07 crore for quarter under review as compared to Rs 2031.74 crore for the quarter ended March 31, 2017.

On consolidated basis, the company has reported a rise of 6.97% in its net profit after taxes, share of profit/ (loss) of associates and joint ventures and non- controlling interests at Rs 1308.96 crore for the quarter ended March 31, 2018 as compared to Rs 1223.71 crore for the corresponding quarter in the FY17. However, total consolidated income of the company decreased by 1.11% at Rs 7279.85 crore for quarter under review as compared to Rs 7361.46 crore for the same quarter ended previous year.

For the year ended March 31, 2018, the company has posted a net loss of Rs 494.59 crore as compared to net loss of Rs 22.84 crore for the previous year. However, total income of company increased by 9.24% at Rs 9075.64 crore for year under review as compared to Rs 8308.28 crore for the year ended March 31, 2017.

For the year ended March 31, 2018, on the consolidated basis, the company has posted a fall of 68.96% in its net profit after taxes, share of profit/ (loss) of associates and joint ventures and non- controlling interests at Rs 2161.55 crore as compared to Rs 6964.37 crore for the same period in the previous year. Total income of company decreased by 15.13% at Rs 27328.22 crore for year under review as compared to Rs 32201.59 crore for the year ended March 31, 2017.


Related News

View all news

NIIT Technologies concludes sale of 88.99% stake in ESRI India Technologies

NIIT Technologies has concluded the sale of 88.99% equity shares in ESRI India Technologies, India to Environment Systems Research Institute Inc., USA. Consequent to above sale, ESRI India Technologies,......

United Bank of India to raise Rs 1,500 crore by various means

United Bank of India has received approval to raise equity capital not exceeding Rs 1,500 crore in one or more tranches during the financial year by way of Qualified Institutions Placement, Public Issue,......

Crisil downgrades DHFL's commercial papers worth Rs 850 crore

Credit Rating Agency Crisil has downgraded Dewan Housing Finance Corporation's commercial paper worth Rs 850 crore from A3+ to A4+. Its rating also continues to be on 'Rating Watch with Negative Implications'.......

Top News

View all news

SRF, NIIT Technologies and United Bank of India to see some action today

SRF has entered into a definitive agreement to sell its Engineering Plastics Business to DSM, the Life Sciences and Materials Sciences Company in an all-cash transaction, amounting to Rs 320 crore. The......

NIIT Technologies concludes sale of 88.99% stake in ESRI India Technologies

NIIT Technologies has concluded the sale of 88.99% equity shares in ESRI India Technologies, India to Environment Systems Research Institute Inc., USA. Consequent to above sale, ESRI India Technologies,......

United Bank of India to raise Rs 1,500 crore by various means

United Bank of India has received approval to raise equity capital not exceeding Rs 1,500 crore in one or more tranches during the financial year by way of Qualified Institutions Placement, Public Issue,......